Post # of 789 [by Aven 1] on the Ranging Bull ADVR Thread links the following list obtained through a Patent Office search concerning Reticulose related patents . Here is the Aven 1 post #789
Friday, 14 May 1999 at 7:27 PM EDT
Hi All, Well well Here's a CORNER everybody should TURN TO !!....Aven1
164.195.100.11
******************************************
I have further reduced the Patent Office information and tabulated the results as follows.
Patent #---—--Date---—----Date-------Name-------Assignee
-------------Filed--------Granted
5,902,786---4/15/97-----5/11/99----Bregman------ADVR
5,892,052---4/6/95------4/6/99-----Kempt, et.al.----Abbott
[Process for making retroviral protease inhibiting compounds]
5,886,036---3/20/97-----3/23/99----Kempt, et.al.--—Abbott
[Retroviral protease inhibiting compounds]
5,849,196---8/7/96------12/15/98---Kochel--------IMM
[Composition containing peptides and nucleic acids and methods of making same]
5,846,987---4/20/97-----12/8/98----Kempt, et.al.--—Abbott
[Retroviral protease inhibiting compounds]
5,837,873---5/24/95-----11/17/98---Norbeck, et.al.--Abbott
[Intermediates of retroviral protease inhibiting compounds]
5,807,840-—11/4/97-----9/15/98----Hirschman-----ADVR
[Method for treating canine distemper]
5,807,839-—4/15/97-----9/15/98----Hirschman-----ADVR
[Method for stimulating red blood cell production]
5,776,933-—5/31/95-----7/7/98-----Gordon, et.al.---Squibb
[Method of inhibiting protease]
5,760,036-—5/31/95-----6/2/98-----Gordon, et.al.---Squibb
[Aminediol protease inhibitors]
As can be seen, Abbott Labs was the first organization to file for a "use" patent [4/6/95] involving Reticulose but it took 4-years to be granted. Squibb was the first assignee granted a Reticulose "use" patent even though their first filing occurred 2-months [5/31/95] after Abbott's first filing [4/6/95]. ADVR's first filing [4/15/97] occurred some 2-years after both the Abbott and Squibb fillings [4/6/95, 5/31/95]. Further, the two more important Hirschman filings occurred some 8-months after the IMM filing [8/7/96] but those ADVR patents were granted some 3-months earlier [9/15/98] than the granting of the IMM patent [12/15/98].
Well King, what the hell does all this mean? Nothing much except, all assignees should make money and competition should keep the price for Reticulose down [even, maybe, a resulting cocktail that uses Reticulose] benefiting the afflicted.
GO FIGURE! |
